Glaxosmithkline says it is recalling the popular heartburn medicine zantac in all markets as a "precaution", days after the us food and drug administration found "unacceptable" levels of probable cancer-causing impurity in the drug zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Heartburn drug zantac australia. Urgent warnings have been issued over a popular heartburn medication, with fears it could contain a chemical linked to cancer risk zantac and its generic equivalents containing ranitidine could be a cancer risk, with tests revealing that nearly all those drugs sold in australia contain a carcinogen called ndma.
heartburn drug zantac australia
Wednesday, april 1, 2020 -- all versions of the heartburn drug zantac have been pulled from the us market due to possible contamination with a probable cancer-causing chemical, the us food and drug administration said wednesday this is the latest step in an ongoing investigation of n-nitrosodimethylamine (ndma) in ranitidine medications, the agency noted. "zantac brand products and cvs brand ranitidine products have not been recalled, and the fda is not recommending that patients stop taking ranitidine at this time," the company said.. Popular heartburn drugs linked to heightened covid-19 risk (h2 blockers, which include pepcid and zantac, work by blocking receptors on stomach tissue cells that trigger acid production)..
